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We have undertaken a biochemical analysis of the regulation of the G1/S-phase transi-
tion and commitment to the cell cycle in the fission yeast Schizosaccharomyces pombe. The
execution of Start requires the activity of the Cdc2 protein kinase and the Sctl /CdclO
transcription complex. Progression through G1 also requires the Ranl protein kinase
whose inactivation leads to activation of the meiotic pathway under conditions normally
inhibitory to this process. We have found that in addition to Cdc2, Sctl/CdclO complex
formation requires Ranl. We demonstrate that the Pucl cycin associates with Ranl and
CdclO in vivo and that the Ranl protein kinase functions to control the association
between Pucl and CdclO. In addition, we present evidence that the phosphorylation state
of CdclO is altered upon inactivation of Ranl. These results provide biochemical evidence
that demonstrate one mechanism by which the Ranl protein kinase serves to control cell
fate through CdclO and Pucl.
INTRODUCTION
The mechanism by which yeast cells monitor environ-
mental conditions and respond by either arresting in
G1 to initiate mating and subsequent meiotic functions
or by proceeding through the mitotic cell cycle is not
well understood. It is clear that passage through Start
and commitment to the mitotic cell cycle requires the
function of the Cdc2/CDC28 protein kinase (Hartwell
et al., 1974; for review, see Reed, 1992). Genetic screens
in the budding yeast Saccharomyces cerevisiae have
identified three CLN genes, CLN1, -2, and -3, that
function to activate the CDC28 kinase at Start (Cross
and Blake, 1988; Nash et al., 1988; Richardson et al.,
1989). The three CLN genes exhibit some functional
redundancy because inactivation of any CLN pair re-
sults in a viable cell whereas inactivation of all three
genes results in cell cycle arrest at Start. A single
CLN-type cyclin, Pucl, that shares considerable amino
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acid similarity with CLN3 has been identified in fis-
sion yeast (Forsburg and Nurse, 1991).
It is likely that one role of the CLN/CDC28 protein
kinase at Start is to directly activate transcription fac-
tors involved in regulating genes required for DNA
replication. The SW14, SWI6, and MBP1 proteins were
identified in S. cerevisiae as factors required for the
expression of the HO endonuclease and DNA replica-
tion genes, respectively (Breeden and Nasmyth, 1985;
Andrews and Herskowitz, 1989a; Koch et al., 1993).
SWI6 associates with MBP1 and binds to the Mlu cell
cycle box to activate many genes involved in DNA
synthesis (for review, see Andrews, 1992; Dirick et al.,
1992; Lowndes et al., 1992a). In addition, SW16 associ-
ates with SWI4 and binds to the cis-acting regulatory
motif known as the Swi-dependent cell cycle box to
activate the expression of the HO, CLN1, CLN2,
HCS26, and PCL2 (ORFD) genes at the G1/S-phase
transition (Andrews and Herskowitz, 1989a; Nasmyth
and Dirick, 1991; Ogas et al., 1991; Measday et al.,
1994). The transcriptional regulation of CLN1 and
CLN2 has been implicated in coupling cell size to
growth rate through cAMP regulation (Baroni et al.
1994; Tokiwa et al., 1994).
In the fission yeast Schizosaccharomyces pombe, the
Cdc2 protein kinase is required for the execution of
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Start as well as for entry into mitosis. Cells that arrest
in G1 due to inactivation of cdc2 are capable of conju-
gation if challenged by a cell of the opposite mating
type under appropriate nutritional conditions (Nurse
and Bisset, 1981). To date, three B-type cyclins, cdc13,
cigl, and cig2 and one Cln-type cyclin, pucl, have been
identified in fission yeast (Booher and Beach, 1988;
Hagan et al. 1988; Bueno et al., 1991; Forsburg and
Nurse, 1991; Bueno and Russell, 1993; Connolly and
Beach, 1994). Of the three B-type cyclins, only Cdc13 is
essential for growth (Booher and Beach, 1988). The
inactivation of cigl or cig2 does not lead to loss of cell
viability (Bueno et al., 1991; Bueno and Russell, 1993;
Connolly and Beach, 1994). Similarly, cells that carry a
pucl null allele are viable and display no abnormal cell
cycle phenotype, suggesting that additional, as yet
unidentified, CLNs might exist in fission yeast (Fors-
burg and Nurse, 1994; T.C., unpublished results).
In addition to the Cdc2 protein kinase, the execution
of Start in fission yeast requires the cdclO and sctl
(resl) genes (Nurse and Bisset, 1981; Tanaka et al.,
1992; Caligiuri and Beach, 1993). Haploid cells carry-
ing mutations in either cdclO or sctl arrest in G, and
mate to form diploid cells under appropriate nutri-
tional conditions. The Sctl and CdclO proteins share
amino acid sequence similarity to the S. pombe pctl
gene product and the SW14, SW16, and MBP1 family of
transcriptional regulators in S. cerevisiae (Aves et al.,
1985; Breeden and Nasmyth, 1987b; Andrews and
Herskowitz, 1989b; Tanaka et al., 1992; Caligiuri and
Beach, 1993; Koch et al., 1993; Miyamoto et al., 1994;
Zhu et al., 1994). The results of both genetic and bio-
chemical studies suggest that CdclO and Sctl function
together as a heteromeric transcription complex to
activate several periodically expressed genes at the
GI /S-phase transition, which include cdc22, cdcl8, and
cdtl (Kelley et al., 1993; Hofmann and Beach, 1994).
The CdclO/Sctl complex is thought to bind to Mlu cell
cycle box-like elements, which have been shown to be
sufficient to confer cell cycle periodicity to a reporter
gene (Lowndes et al. 1992b).
Cells that lack the sctl gene, unlike those that lack
cdc2 or cdcl0, will conjugate even when grown on rich
medium and thus bypass the normal requirement of
nutritional deprivation for the activation of the mating
pathway (Caligiuri and Beach, 1993). This phenotype
is reminiscent of that which results from the loss of
another cell cycle regulator, ranl (patl; Iino and
Yamamoto, 1985; Nurse, 1985). The ranl gene encodes
a protein kinase that functions to prevent activation of
the meiotic pathway under conditions that normally
promote vegetative growth (McLeod and Beach,
1986). Cells that carry inactivating mutations in ranl
also bypass the requirement of nutritional starvation
for conjugation. In addition, ranl mutants undergo
meiosis and sporulation from the haploid state and are
thus alleviated of the requirement for heterozygosity
Table 1. List of S. pom1be strains
Strain Genotype
SP 191 hi rantl-114 leul-32 ura4-d18
SP 201 hi " Ieul-32 ade6-210
SP 315 h1" ranl-114 leuil-32 ade6-216
SP 357 11i cdc2-33 leiul-32 ura4-D12 ade6-210
SP 871 11( rnil::adh letil-32 ura4-D12 ade6-210
SP 963 hIV cdc22-M45 leuil-32
SP 965 h - cdclO-129 leutl-32 uIra4-D12 ade6-210
SP 1296 h'- cdc2-M72 leuil-32 ura4-D12 ade6-210
SP 1297 hi- cdclO::ura4 sctl-l ura4-D18 leiil-32
JZ 420 It' rantl::ura mei2::ura ura4-D18 leil-32 ade6-M216
at the mating type locus for the activation of these
functions. Temperature-sensitive mutations in ran1
thus cause deregulation of the molecular events at
Start and allow the meiotic and cell division pathways
to become insensitive to the normal environmental
cues that govern cell fate.
It is clear that both Cdc2 and Ranl are essential for
maintenance of the mitotic cell cycle and progression
through Start, though the substrates of both of these
protein kinases have yet to be identified. We have thus
undertaken a biochemical analysis of these proteins to
obtain a better understanding of their role in the reg-
ulation of Start. We demonstrate that the Pucl cyclin is
associated with both the Cdc2 and Ranl protein ki-
nases in vivo. In addition, we show that Pucl is com-
plexed with CdclO in vivo and that Ranl is required
for this association. Finally, we show that Ranl is
required for formation of the heteromeric Sctl /Cdcl0
transcription complex and that inactivation of this
protein kinase leads to an alteration in the phosphor-
ylation state of Cdc10. In the accompanying article, we
present data that demonstrates that Cdc2 also func-
tions to stabilize the Sctl /Cdcl0, thus promoting pro-
gression through the G1 /S-phase transition. Thus,
these results provide biochemical evidence that sug-
gests that the Ranl protein kinase affects cell fate by
promoting Sctl /CdclO complex formation through
Pucl thereby influencing the expression of genes un-
der the control of this transcription complex and ulti-
mately the onset of DNA replication.
EXPERIMENTAL PROCEDURES
Strains and Media
All fission yeast strains were derived from wild-type strains origi-
nally described by Leupold (Leupold, 1970). The strains used in this
study are listed in Table 1. S. pombe was grown in standard YEA, YE,
PM, and PMA media containing additional amino acids, when
indicated, at 75-150 j,g/ml (Beach et al., 1985). Standard genetic
procedures previously described for S. pombe were followed (Gutz et
al., 1974).
Molecular Biology of the Cell1118
Ranl and Cell Cycle Start
Epitope Addition
Pucl and Sctl were tagged at the carboxyl terminus with a triple
tandem HAl epitope (Caligiuri and Beach, 1993; this study). The
plasmid pGETP1 contains this epitope bounded by NotI restriction
sites (Field et al., 1988; Tyers et al., 1992). Site-directed mutagenesis
was employed to place NotI restriction sites at the carboxyl terminus
of both pucl and sctl reading frames and the triple tandem hemag-
glutinin (HA) epitope NotI cassette was ligated into the pucl and
sctl cDNA constructs. The addition of the epitope in the correct
reading frame was confirmed by DNA sequence analysis with a
semiautomatic DNA sequencer (Applied Biosystems, Foster City,
CA). The monoclonal (12CA5) and polyclonal (HA1.1) anti-HA
antibodies recognizing the HA epitope were purchased from Boehr-
inger Mannheim (Indianapolis, IN) and Babco Berkeley Laboratory
(Richmond, CA), respectively.
Immunoprecipitation and Western Blotting
S. pombe cell-free lysates were prepared essentially as described
(Booher et al., 1989). Cells were quickly disrupted by vortex mixing
in the presence of glass beads in buffer H [25 mM Tris(hydroxym-
ethyl)aminomethane (Tris), pH 7.5, 1 mM dithiothreitol (DTT), 60
mM }3-glycerol phosphate, 15 mM p-nitrophenyl phosphate, 15 mM
EGTA, 15 mM MgCl2, 0.1 mM NaF, 0.1 mM sodium orthovanadate,
0.1% Nonidet P-40, 1 mM phenylmethylsulfonyl fluoride (PMSF), 2jig/ml leupeptin, 2 ,ug/ml aprotinin, 2 ,ug/ml pepstatin, 10 jig/ml
L-1-tosylamide-2-phenylethyl chloromethyl ketone, and 7-amino-i-
chloro-3-tosylamido-2-heptanonel. After lysis, an equal volume of
ice-cold buffer H was added to the beads, and lysate was collected
and centrifuged at 11,000 x g for 15 min. The supematant was
collected, and the protein concentration was determined by a col-
orimetric assay using Bradford reagent (Bradford, 1976). Cig2 does
not quantitatively associate with Cdc2 in extracts prepared from
asynchronously growing cultures even when expressed constitu-
tively from a heterologous promoter. Therefore, the cig2-HA gene
was expressed in a temperature-sensitive cdc22 strain (SP 963) ar-
rested for 3 h in S-phase and released at the permissive temperature
for the preparation of protein extracts from a synchronized culture.
Immunoprecipitations were performed with 10-50 mg of soluble
protein extract and 1.0 ,ul of antibody, as specified, and were rotated
at 4°C. After 2 h, 20 ,ul of a 1:1 slurry of protein A-Sepharose
(Pharmacia, Piscataway, NJ) was added and the incubation was
continued for an additional 30 min at 4°C. The immune complexes
were recovered by centrifugation and washed three times in 1.0 ml
of 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 0.5%
Nonidet P-40, 1 mM DTT, and 1 mM PMSF. The samples were
resuspended in Laemmli buffer and the proteins were resolved by
conventional SDS-PAGE.
For immunoblotting, the proteins were transferred to nitrocellu-
lose for 30 to 60 min at 400 mA with a semidry transfer apparatus
(Millipore, Bedford, MA). After the transfer, the immunoblots were
blocked in TBST (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.05%
Tween 20) containing 5% nonfat dry milk for 30 min at 37°C. Blots
were incubated with a 1:1000 dilution of antibody in TBST contain-
ing 5% milk for 2 h at room temperature. The blots were washed for
three 20-min periods in TBST then incubated with a 1:50,000 dilu-
tion of an anti-mouse or anti-rabbit Fc antibody as appropriate
(Jackson Immuno Research Laboratories, West Grove, PA) in TBST
containing 5% milk for 1 h at room temperature. The proteins were
visualized with an enhanced chemiluminescence kit (Amersham,
Arlington Heights, IL) and conventional autoradiography.
Metabolic Labeling and Two-Dimensional Tryptic
Peptide Mapping
S. pombe cells were grown for approximately 16 h in phosphate-free
minimal medium in which the NaH2PO4 was reduced to 1 mM and
the potassium phthalate was replaced with sodium acetate (Moreno
et al., 1991). The cells were harvested, in 5-10 ml containing 1 x 107
cells per ml, washed with H20, and resuspended in phosphate-free
minimal medium supplemented with 50 ,uM NaH2PO4 The volume
of the cdc2-M72 culture was increased to 35 ml to allow the recovery
of enough CdclO protein for two-dimensional peptide analysis. The
cultures were incubated for 2 h prior to the addition of
[32P]orthophosphate (1 mCi/5 ml of culture) and labeled for 3 to 4 h.
Extracts were prepared for immunoprecipitation as described
above.
The proteins subjected to tryptic mapping were eluted from gel
slices in 50 mM ammonium bicarbonate ovemight in the presence of
20 tig of RNase. The proteins were precipitated with trichloroacetic
acid and digested with 10 ,ug of L-1-tosylamide-2-phenylethyl chlo-
romethyl ketone-trypsin as described (van der Geer et al., 1993).
Peptide maps were produced by two-dimensional separation of the
phosphopeptides on TLC plates. The first dimension was electro-
phoresis in buffer at pH 1.9 and the second dimension was chroma-
tography in isobutyric acid buffer (van der Geer et al., 1993).
Protein Kinase Assays
Histone HI kinase assays were performed as described (Booher et
al., 1989). The immunoprecipitates used in kinase reactions were
washed once with 1.0 ml of kinase reaction buffer (50 mM Tris-HCl,
pH 7.5, 10 mM MgCl2, and 1 mM DTT) and resuspended in 20 jLd of
kinase reaction buffer containing 0.125 mg/ml histone HI. The
immunoprecipitates were preincubated for 15 min at the indicated
temperature, 5 ,ul of [y-32PIATP solution (0.5 ,uM ATP, 0.5 j,Ci/,ul)
was added, and the incubation was continued for an additional 10
min. The reactions were terminated with the addition of Lamelli
buffer.
Gel Retardation Assays
Cells were grown to a density of 5 x 106 to 1 x 107 cells/ml in
minimal selective medium, harvested by centrifugation, and
washed once in lysis buffer (50 mM Tris, pH 7.5, 0.3 M KCl, 10%
glycerol, 10 mM MgCl2, 20 mM ,3-glycerophosphate, 5 mM EDTA,
0.1 mM sodium vanadate, 1 mM DTT, 0.2% Nonidet P-40, 1 mM
PMSF, 2 ,tg/ml leupeptin, 2 j,g/ml aprotinin, and 2 JLg/ml pepsta-
tin). The cells were disrupted by vortexing with glass beads. Cellu-
lar debris was cleared from the lysate by centrifugation for 20 min
in a microcentrifuge. All manipulations were performed at 4°C. The
supernatant was collected and the protein concentration was deter-
mined by a colorimetric assay using Bradford reagent (Bradford,
1976).
The restriction fragments used for probes were recovered from
low-melting-temperature agarose in Tris-acetate buffer and end la-
beled with the Klenow fragment of DNA polymerase I in the
presence of [a-32P]dATP (Sambrook et al., 1989). The binding reac-
tions were performed in a volume of 20 j,l and contained 20 mM
Tris (pH 7.5), 50 mM KCl, 10 mM MgCl2, 5% glycerol, 2 mM DTT,
1 mM ATP, and 0.1 mg/ml poly(dIdC)-poly(dIdC) (Pharmacia).
After the addition of the protein extracts (20 /.Lg), the reaction
mixtures were incubated at room temperature for 10 min. Approx-
imately 1 ng of probe at 107 cpm/j,g was added to the binding
reaction and the incubation was continued for an additional 10 min.
Where noted, a 50-fold molar excess of unlabeled promoter frag-
ment was added at the same time as the probe. The anti-cdclO
antibody and preimmune sera (from the same rabbit) were diluted
1:10 in binding buffer and I ,ul was added after the binding the
reaction. The HAl monoclonal antibody 12CAl (Boehringer) was
purified on protein A-Sepharose as described by the manufacturer.
The antibody was diluted 1:10 in binding buffer and 1 ,1. was added
to the reaction as above. The binding reaction was incubated for an
additional 10 min after the addition of antibodies. The DNA-protein
complexes were resolved on a 4% polyacrylamide gel (30:0.8 cross-
linking) in 0.5x Tris-borate EDTA. The gels were dried on What-
man 3 MM paper and subjected to autoradiography.
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RESULTS
Puci Associates with the CdclO Transcription
Factor In Vivo
To investigate the role of the various cyclins in the
fission yeast cell cycle, a triple tandem copy of the
influenza HA epitope (HA1) was placed in-frame
at the carboxyl terminus of the pucl, cigl, and cig2
cDNAs for the immunological detection of these pro-
teins (Field et al., 1988; Tyers et al., 1992). Cell-free
lysates were prepared from strains expressing the
puci-HA, cigl-HA, and cig2-HA genes under the con-
trol of the thiamine-repressible nmtl promoter (Maun-
drel, 1993). Immunoblots of Pucl-HA, Cigl-HA, and
Cig2-HA, immunoprecipitated with the monoclonal
anti-HA antibody (12CA5) and probed with a rabbit
anti-HA polyclonal antibody (HAl.l), revealed bands
of 43, 50, and 55 kDa, corresponding to the predicted
molecular weights of these proteins, respectively (Fig-
ure 1A, lanes 2-4). The specificity of the immunopre-
cipitations is shown by the lack of these bands when
normal mouse serum was substituted for the anti-HA
antibody (Figure 1A, lane 1). In addition, these band
were absent in lysates prepared from wild-type strains
(our unpublished observation).
The cyclins were assayed for association with Cdc2
by blotting anti-HA immunoprecipitates (12CA5) pre-
pared from strains producing the HA-tagged cyclins,
with a polyclonal antibody (G8) directed against fis-
sion yeast Cdc2. Cdc2 was found to coimmunoprecipi-
tate with Pucl-HA, Cigl-HA, and Cig2-HA (Figure
1B, lanes 2-4). Histone Hi kinase activity was de-
tected in Pucl-HA and Cigl-HA (a representative B-
type cycin) immunoprecipitates upon addition of hi-
stone Hi and [y-32P]ATP (Figure 1B, lanes 6 and 7 and
lanes 10 and 11, respectively). The kinase activity was
temperature-sensitive when Pucl-HA or Cigl-HA
were immunoprecipitated from strains harboring the
cdc2-M72 mutation (SP 1296; Figure 1B, lanes 9 and 13,
respectively). Histone Hi kinase activity was not de-
tected in immunoprecipitates with normal mouse se-
rum, indicating that this activity was specific to the
Cdc2/cyclin complex (Figure 1B, lane 5). Identical re-
sults were obtained with Cig2-HA and Cdc13 immu-
noprecipitates (our unpublished observation). These
results demonstrate that these cyclins associate with
and activate the Cdc2 protein kinase.
It has been demonstrated previously that CdclO is a
phosphoprotein whose activity is required for the ex-
ecution of Start (Nurse and Bisset, 1981; Simanis and
Nurse, 1989). The identity of the protein kinase re-
quired for this phosphorylation has, however, re-
mained elusive. We therefore set out to determine
whether CdclO was associated with any of the Cdc2/
cyclin complexes identified thus far in fission yeast.
Cyclin-HA immunoprecipitates (Pucl-HA, Cigl-HA,
and Cig2-HA) were prepared from the appropriate
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Figure 1. Pucl-HA associates with the CdclO transcription factor
in vivo. (A) Anti-HA immunoblot of immunoprecipitates with nor-
mal mouse serum (pre, lane 1), Pucl-HA (lane 2), Cigl-HA (lane 3),
and Cig2-HA (lane 4) anti-HA antibodies. (B) Anti-Cdc2 immuno-
blot of immunoprecipitates with normal mouse serum (lane 1),
Pucl-HA (lane 2), Cigl-HA (lane 3), or Cig2-HA (lane 4) anti-HA
antibodies. Histone HI kinase assays were performed with either
Pucl-HA (lanes 6-9) or Cigl-HA (lanes 10-13) immunoprecipitates
from wild-type cells expressing the HA-tagged genes (lanes 6, 7, 10,
and 11) or a cdc2-M72 mutant expressing the HA-tagged genes
(lanes 8, 9, 12, and 13). The kinase assays were performed at either
25°C (lanes 6, 8, 10, and 12) or 37°C (lanes 7, 9, 11, and 13). (C)
Anti-cdclO immunoblot of immunoprecipitates with normal mouse
serum (lane 1), Pucl-HA (lane 2), Cigl-HA (lane 3), and Cig2-HA
(lane 4) anti-HA antibodies. (D) Anti-HA immunoblot of immuno-
precipitates with normal mouse serum (lane 1) and anti-CdclO
antibodies (lane 2). Histone HI kinase assays of the normal mouse
serum (lane 3) and anti-CdclO immunoprecipitates (lane 4) from the
Pucl-HA extract.
strains, resolved by SDS-PAGE, and blotted to nitro-
cellulose membrane. The Western blot was probed
with a polyclonal antisera directed against fission
yeast CdclO, and a band corresponding to CdclO was,
in fact, detected in the Pucl-HA immunoprecipitate
(Figure 1C, lane 2). This association, however, was not
detected in either the Cigl-HA or Cig2-HA immuno-
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Figure 2. Pucl and the Ranl kinase asso- A
ciate in vivo. (A) Anti-HA immunoblot of
immunoprecipitates with normal mouse se-
rum or the anti-HA antibody from a lysate <
r M~~~~~IIprepared from a wild-type strain producing I_ II
Pucl-HA protein (lanes 1 and 2, respec- 2O X uX e
tively) and anti-Ranl immunoprecipitates a C t Z - X °
from lysates prepared from a wild-type or a
Ranl overproducing strain, both producing p43Puc1-P . p43pUCl-P - 5
Pucl-HA (SP 871) (lanes 3 and 4, respective- p43Pucl - 3 w v p43PucI
ly). (B) Anti-Ranl immunoblot of immuno- W IgG - 4
precipitates from the Pucl-HA lysate using p52ran1 o _ _
a normal mouse serum, the anti-HA anti-
body of the anti-Ranl antibody (lanes 5-7, 1 2 3 4 5 6 7 8 9 10
respectively). (C) Anti-HA immunoblot of
immunoprecipitates from the Pucl-HA lysate using either normal mouse serum (lane 8) or the anti-HA antibody and subjected to treatment
with either buffer only (lane 9) or 1 U of calf intestinal alkaline phosphatase (lane 10) for 15 min at 37°C.
precipitates (Figure 1C, lanes 3 and 4). In the recipro-
cal experiment, Pucl-HA was detected in an anti-
CdclO immunoprecipitate (Figure 1D, lane 2). The
presence of Cdc2 in the CdclO immunoprecipitate was
suggested by the presence of histone Hi kinase activ-
ity (Figure 1D, lane 4). The specificity of the interaction
between Pucl and CdclO is shown by the lack of a
band when normal mouse serum or rabbit preimmune
serum were used in the immunoprecipitation (Figure
1, A, lane 1, and D, lane 3, respectively). We conclude
that Pucl, and presumably Cdc2, is physically associ-
ated with the CdclO transcription factor in vivo.
Pucl Is Associated with Ranl In Vivo
Overexpression of pucl partially rescues strains carrying
the ranl-114 temperature-sensitive mutation (Forsburg
and Nurse, 1994). We therefore investigated the possi-
bility that Pucl and Ranl may be physically associated in
a multiprotein complex in vivo. Cell-free lysates were
prepared from strains that produce Pucl-HA and immu-
noprecipitations were performed with either anti-HA or
anti-Ranl monoclonal antibodies. The immunopre-
cipitates were resolved by SDS-PAGE, blotted to nitro-
cellulose, and probed with either anti-HA or anti-Ranl
polyclonal antibodies. Anti-Ranl immunoprecipitates
probed with the anti-HA antibody revealed the presence
of the full-length form of Pucl-HA (Figure 2A, lane 3).
Similarly, anti-HA immunoprecipitates probed with an
anti-Ranl polyclonal antibody revealed the presence of
the 52-kDa Ranl protein (Figure 2B, lane 6). These results
demonstrate that Ranl and Pucl are associated in vivo.
Ranl was not detected in anti-HA immunoprecipitates
from lysates prepared from strains that produced
Cigl-HA or Cig2-HA, indicating that the interaction be-
tween Ranl and cyclin is specific to Pucl, the CLN-type
cyclin (our unpublished observation).
Anti-Pucl-HA immunoprecipitates from concen-
trated lysates probed with the anti-HA antibody re-
vealed three specific bands (Figure 2A, lane 2). To
investigate whether the slower-migrating form was
phosphorylated Pucl, a Pucl-HA immunoprecipitate
was treated with calf intestinal alkaline phosphatase.
This slower migrating from of Pucl-HA did indeed
collapse into the intermediate form after phosphatase
treatment (Figure 2C, lanes 9 and 10). Thus, in all
probability, the slower-migrating band represents the
phosphorylated form of Pucl-HA and the intermedi-
ate band represents the nonphosphorylated form. The
fastest migrating band is presumably a degradation
product. Immunoprecipitation of Pucl-HA, from ex-
tracts prepared from a strain that overexpresses the
Ranl kinase, reveals an substantial increase in the
phosphorylated form of Pucl-HA (Figure 2A, lane 4).
These results suggest that Pucl is a phosphoprotein in
vivo and that Pucl may be a substrate of the Ranl
kinase. We cannot draw any conclusions regarding the
relative stoichiometries of these proteins, because to
resolve the phosphorylated and nonphosphorylated
forms of Pucl, it was necessary to perform the an-
ti-HA immunoprecipitate from less protein than the
anti-Ranl immunoprecipitate (10 and 50 mg, respec-
tively) and to obtain a shorter exposure of the autora-
diograph of the Pucl-HA immunoprecipitates than
the Ranl immunoprecipitates.
The Association between Pucl and CdclO Requires
Ranl
We next addressed whether the association between
Pucl-HA and CdclO was dependent on either Ranl or
Cdc2 protein kinase activity. A wild-type strain and
strains carrying either the cdc2-M72 (SP 1296) or ranl-
114 (SP 315) mutations expressing pucl-HA were
grown to mid-logarithmic phase at the permissive
temperature and then half of the culture was shifted to
the restrictive temperature (36°C) for 2 h. Protein ex-
tracts were prepared and immunoprecipitations were
performed with the anti-HA antibody. The immuno-
precipitates were resolved by SDS-PAGE, transferred
to nitrocellulose membranes, and probed with either
the anti-CdclO or anti-HA antibody. CdclO was clearly
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cycle arrest and activation of meiotic functions. To
eliminate the possibility that the loss of the association
between Pucl-HA and CdclO was due to this effect
rather than the specific loss of the Ranl kinase, we
examined this interaction in cells that carry a ranl null
allele suppressed by deletion of the mei2 gene (JZ 420;
Wantanabe et al., 1988; Wantanabe and Yamamoto,
1994). As shown above, anti-HA immunoprecipitates
from a Ranl + strain contain CdclO (Figure 3C, lane 2).
In contrast, anti-HA immunoprecipitates from the
ranl::ura strain do not (Figure 3C, lanes 3). These
results demonstrate that the association between
Pucl-HA and CdclO requires Ranl, but not Cdc2,
protein kinase activity.
-HA
- p43Vc'n
cx.CdclQ * -- c85C'C-
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Figure 3. Association between Pucl and CdclO requires Ranl.
Cultures of a wild-type strain or strains carrying either the cdc2-M72
or ranl-114 temperature-sensitive alleles that produce Pucl-HA
were grown at 27°C, and then one-half of the culture was shifted to
36'C for 3 h. Cell-free extracts were prepared for immunoprecipi-
tation. (A) Anti-CdclO (Top) or anti-HA (Bottom) immunoblots of
immunoprecipitations from extracts prepared from the indicated
strains with either normal mouse serum (lane 1) or the anti-HA
antibody (lanes 2-7). (B) Anti-CdclO immunoblot of immunopre-
cipitations using either preimmune serum (lane 1) or the anti-CdclO
antibody from lysates prepared from wild-type cells grown at 27'C
(lane 2) or ranl-114 cells grown at 27°C (lane 3) or 36'C (lane 4). (C)
Anti-HA (top) or anti-CdclO (bottom) immunoblots of immunopre-
cipitations with normal mouse serum from the ranl + extract (pre,
lane 1) or the anti-HA antibody from the ranl + or ranl::ura extracts
(lanes 2 and 3, respectively).
present in Pucl-HA immunoprecipitates from lysates
prepared from wild-type cells cultured at both permis-
sive (270C) and restrictive (36°C) temperatures (Figure
3A Top, lanes 2 and 3). Similarly, CdclO was present in
Pucl-HA immunoprecipitates from lysates prepared
from the cdc2-M72 strain cultured at both tempera-
tures (Figure 3A, top, lanes 6 and 7). The lack of a
requirement for Cdc2 is not specific to this allele,
CdclO and Pucl-HA were also found to be associated
upon inactivation of the cdc2-33 allele (our unpub-
lished observation). The association between Pucl-HA
and CdclO was, however, abolished upon inactivation
of the thermolabile Ranl kinase (Figure 3A, top, lane
5). The lack of CdclO in the Pucl-HA immunoprecipi-
tate from the ranl-114 lysate is not due to a loss of
Pucl-HA, as approximately equal amounts of the pro-
tein are present in the wild-type, ranl-114, and cdc2-
M72 extracts (Figure 3A, bottom, lanes 2-7). Similarly,
the level of CdclO is not affected by inactivation of
Ranl (Figure 3B, lanes 2-4, respectively). Growth of
ranl-114 strains at elevated temperature leads to cell
The Association betwveen CdclO and Sctl Requires
Ranl
As discussed above, the association between Pucl and
CdclO requires a functionally active Ranl kinase. It
was therefore of interest to determine whether the loss
of ranl would have an effect on CdclO/Sctl complex
formation since, as described in the accompanying
article, Cdc2 activity is required for the formation of
this transcription complex. Cultures of a wild-type
strain and a ranl-1 14 temperature-sensitive strain
both expressing the sctl-HA gene were grown to mid-
logarithmic phase at the semipermissive temperature
for the ranl-114 mutation (27°C), divided in half, and
then grown at either 27°C or 36°C. In this experiment,
27°C was chosen because we found this to be the
optimal temperature for the growth of other strains
used in these studies. Cell-free lysates were prepared,
and CdclO and Sctl-HA were immunoprecipitated.
The immunoprecipitates were resolved by SDS-PAGE,
blotted to nitrocellulose, and probed with either anti-
CdclO or anti-HA antibodies. The Sctl/CdclO com-
plex was clearly detected at both temperatures when
Sctl-HA was immunoprecipitated from wild-type ex-
tracts and probed with the anti-CdclO antibody (Fig-
ure 4A, lanes 6 and 7). Interestingly, CdclO was not
present in anti-Sctl-HA immunoprecipitates from the
ranl-114 extracts prepared from cells cultured at ei-
ther the permissive and restrictive temperatures (Fig-
ure 4A, lanes 8 and 9, respectively). Anti-CdclO im-
munoprecipitates from each extract were blotted with
the anti-CdclO antibody to assess whether the loss of
the interaction was due to a loss of CdclO. We found
that approximately equal amounts of CdclO were
present in each extract (Figure 4A, lanes 2-5). Simi-
larly, we found that Sctl-HA was clearly present in all
of the extracts (Figure 4B, lanes 2-5). The level of
Sctl-HA was, however, reduced upon the complete
inactivation of Ranl (Figure 4B, lane 5). Thus, under
conditions where Ranl is inactivated, Sctl and CdclO
are both present yet their interaction is abolished.
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These results suggest that Ranl function is required
for the association of Sctl with CdclO.
The CdclO S196D Mutant Bypasses the Requirement
of Ranl for Sctl/CdclO Complex Formation
It has been shown previously that Cdc2 function is
required for the DNA-binding activity of the Sctl/
CdclO complex (Reymond et al., 1993). A Cdc2 con-
sensus site within CdclO that contains Ser-196 has
been identified. Results from the accompanying article
suggest that phosphorylation of CdclO at Ser-196 is
necessary for its stable association with Sctl. The re-
sults presented above suggest that Ranl might influ-
ence CdclO/Sctl complex formation by controlling the
ability of the Pucl/Cdc2 protein kinase to associate
with and thus presumably phosphorylate CdclO. If
this is true, then one prediction that follows is that the
loss of Ranl kinase activity would prevent the phos-
phorylation of CdclO at Ser-196. To address this issue,
we performed a metabolic labeling experiment. Plas-
mids carrying the cdclO+ gene were transformed into
a ranl + strain (SP 1297) and a ranl - strain (SP 191) that
carries the temperature-sensitive ranl-114 mutation.
Cultures of these transformants were grown at the
restrictive temperature for the ranl-114 mutation
(36°C) and labeled with [32Plorthophosphate. After 3 h
of growth at the restrictive temperature, cell-free ly-
sates were prepared and CdclO was immunoprecipi-
tated with the anti-CdclO antibody. The CdclO immu-
noprecipitates were resolved by SDS-PAGE and
subjected to autoradiography. The 32P-labeled CdclO
was eluted from the gel and digested with trypsin. The
tryptic peptides were resolved by two-dimensional
chromatography, and the maps were visualized by
phosphorimage analysis (van der Geer et al., 1993;
Fuji, Stamford, CT). The tryptic digestion of Cdc1O+
from the extract prepared from the Ranl + strain gen-
erated two major spots (Figure 5, spots 1 and 2) and a
minor spot (spot 3). The tryptic digestion of Cdc1O+
immunoprecipitated from the Ranl- extract also gen-
erated two major spots; however, spot 2 is missing and
an additional spot (spot 4) appears (Figure 5). The
results from the accompanying article demonstrate
that spot 2 results from phosphorylation of Ser-196.
Identification of the residue whose phosphorylation is
responsible for spot 4 awaits further analysis. Thus,
inactivation of the Ranl kinase results in the loss of
phosphorylation at Ser-196 and the consequent phos-
phorylation of an additional, as yet unidentified, site
within CdclO.
We have provided strong evidence that phosphory-
lation of CdclO at Ser-196 and thus its association with
Sctl is controlled, in part, by the Ranl kinase. It fol-
lows, therefore, that substitution of Ser-196 with Asp,
thus potentially mimicking phosphorylation at this
site, would bypass the requirement of Ranl for Sctl/
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Figure 4. Association between CdclO and Sctl requires Ran 1.
Cultures of wild-type or ranl-114 cells producing the Sctl-HA
protein were grown at 27'C to mid-logarithmic phase and then half
of the culture was shifted to 36°C for 3 h. Cell-free extracts were
prepared for immunoprecipitation. (A) Anti-CdclO immunoblot of
immunoprecipitations using a preimmune serum (lane 1), the anti-
CdclO antibody (lanes 2-5), or the anti-HA antibody (lanes 6-9). (B)
Anti-HA immunoblot of immunoprecipitations using normal
mouse serum (lane 1) or the anti-HA antibody (lanes 2-5).
CdclO complex formation, as described in the accom-
panying article for Cdc2. Cultures of strains carrying
the ranl-114 mutation (SP 191) expressing Sctl-HA
and either CdclO+ or mutants in which Ser-196 was
replaced with Asp (S196D) or Ala (S196A) were grown
at 27°C and then split and grown at either 27°C or
36°C for 3 h. Cell-free extracts were prepared and
anti-CdclO, and anti-HA immunoprecipitates were
blotted with either the anti-CdclO (Figure 6A) or the
anti-HA (Figure 6B) antibodies. As expected from our
results described above, Cdc1O+ was found to be as-
sociated with Sctl-HA when the strain was grown at
the permissive temperature (Figure 6A, lane 8) but
not, however, upon inactivation of Ranl by incubation
at the restrictive temperature (Figure 6A, lane 9). The
CdclO S196A mutant was unable to complex with Sctl
at either temperature, suggesting that phosphoryla-
tion of Ser-196 is essential for association with Sctl
(Figure 6A, lanes 10 and 11). Interestingly, CdclO
S196D was found complexed with Sctl at both the
permissive and restrictive temperatures for this muta-
tion (Figure 6A, lanes 12 and 13). The overall level of
Cdc1O+, S196A, S196D (Figure 6A, lanes 1 and 2, lanes
3 and 4, and lanes 5 and 6, respectively), or Sctl
(Figure 6B, lanes 2-7) did not change significantly
upon incubation at the restrictive temperature. These
results demonstrate that the CdclO S196D mutant by-
passes the requirement for Ranl activity for Sctl/
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Figure 5. Phosphorylation of CdclO at Ser-196 is controlled by Ranl. 32P-labeled CdclO immunoprecipitates from extracts prepared from
Ranl+ and Ranl - cells were resolved by SDS-PAGE, recovered from gel slices, and subjected to proteolytic digestion with trypsin. The
32P-labeled tryptic peptides were resolved by two-dimensional chromatography and visualized by phosphorimage analysis.
CdclO complex formation. In addition, the results sug-
gest that Ranl functions in cooperation with Cdc2 to
control the phosphorylation of Ser-196 within CdclO.
As described above, Ranl appears to control the abil-
ity of Pucl, and presumably Cdc2, to associate with
CdclO. The phosphorylation of CdclO at Ser-196 may
thus be regulated by Ranl through Pucl. In this man-
ner, Ranl may function to control the association be-
tween CdclO and Sctl.
cdcclO cdc10
cdc1O+ S196A S196D
27 36 27 36 27 36
1 2 3 4 5 6
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Figure 6. CdclO S196D mutant bypasses the requirement of Ranl
for Sctl/CdclO complex formation. Cultures of ranl-114 strains that
coexpressed sctl-HA and cdM1OM, cdclO S196A, or cdclO S196D were
grown to mid-logarithmic phase at 27'C and half of the culture was
then shifted to 36°C for 3 h as indicated. Cell-free extracts were
prepared for immunoprecipitation. (A) Anti-CdclO immunoblot of
anti-CdclO immunoprecipitates from the Cdc1O+ extract (lanes 1
and 2), the CdclO S196A extract (lanes 3 and 4), the CdclO S196D
extract (lanes 5 and 6), normal mouse serum immunoprecipitate
from the Cdc1O+ extract (lane 7), anti-HA immunoprecipitates from
the Cdc1O+ extract (lanes 8 and 9), the CdclO S196A extract (lanes 10
and 11), or the CdclO S196D extract (lanes 12 and 13). (B) Anti-HA
immunoblot of a normal mouse serum immunoprecipitate from the
Cdc1O+ extract (lane 1) and anti-HA immunoprecipitates from the
Cdc1O+ extract (lanes 2 and 3), the CdclO S196A extract (lanes 4 and
5), and the CdclO S196D extract (lanes 6 and 7).
The CdclO/Sctl DNA-binding Activity Requires the
Ranl Kinase
As discussed above, the association between Pucl
and CdclO is dependent on a functionally active
Ranl kinase. It was therefore of interest to deter-
mine whether the loss of Ranl had a deleterious
effect on CdclO/Sctl-dependent DNA-binding ac-
tivity, which has been shown previously to require
Cdc2 (Reymond et al., 1993). Cultures of a wild-type
strain (SP 201) and one carrying the ranl-114 muta-
tion (SP 315) were shifted from the permissive
(25°C) to the restrictive (36°C) temperature for the
ranl-114 mutation for 4 h. Aliquots of cells were
removed at hourly intervals and used for the prep-
aration of cell-free extracts. The DNA-binding activ-
ity of CdclO/Sctl in these extracts was assessed
with a gel mobility shift assay using a probe from
the cdc22 promoter (Lowndes et al., 1992b; Caligiuri
and Beach, 1993). We found that the DNA-binding
activity was completely abolished after 3 h of
growth at elevated temperature in extracts prepared
from the ranl-114 strain (Figure 7, lanes 11 and 12).
The kinetics of this loss of activity parallels the loss
of viability of the ranl-1 14 strain upon incubation at
the restrictive temperature (our unpublished obser-
vation). The temperature shift had no effect on the
DNA-binding activity when the extracts were pre-
pared from the wild-type strain (Figure 7, lanes
2-6). This indicates that the Ranl kinase is required
for the DNA-binding activity of the CdclO/Sctl
complex as assayed in vitro. It is likely that this
requirement is due to the loss of the Pucl/CdclO
interaction, and potentially CdclO phosphorylation,
upon inactivation of Ranl.
Molecular Biology of the Cell
Ran1+
I
A
acdc 1 0
1124
Ranl and Cell Cycle Start
hrs. 360C
wild type ranl.ll4
0 2 3 4 0 2 3 4
--
d
a .*
2 3 4 5 6 7 8 9 10 11 12
Figure 7. CdclO/Sctl function requires the Ranl kinase. Cultures
of a wild-type and ranl-114 strains were shifted from 25 to 36°C for
4 h. Aliquots of cells were removed at hourly intervals and used for
the preparation of cell-free extracts. The DNA-binding activity of
CdclO/Sctl was assessed with a gel mobility shift assay using a
probe from the cdc22 promoter. No extract (lane 1), wild-type extract
(lanes 2-7), and ranl-114 extract (lanes 8-12) are shown.
cle, we demonstrate that Cdc2 is required for CdclO/
Sctl complex formation and, therefore, envisaged that
since Ranl is required for Pucl to bind CdclO, it too
might be required for the formation of the heteromeric
transcription complex. This prediction was borne out
when we observed the dissociation of the CdclO/Sctl
complex upon inactivation of Ranl. In addition, we
found that as expected, inactivation of Ranl leads to a
loss of Sctl /Cdc1O DNA-binding activity. In the ac-
companying article (Connoliy et al., 1997), we show
that Ser-196 of CdclO, which lies within a canonical
Cdc2 recognition site, is phosphorylated in vivo. Fur-
thermore, we show that substitution of this serine with
alanine, S196A, results in a loss of CdclO function in
vivo due to the inability of CdclO S196A to associate
with Sctl. Interestingly, substitution of this serine with
aspartic acid, S196D, thus, potentially mimicking
phosphorylation, restores CdclO function and by-
passes the requirement for both Ranl and Cdc2 kinase
activity for Sctl/CdclO complex formation. We dem-
onstrate herein that inactivation of Ranl results in the
loss of phosphorylation of CdclO at Ser-196 and in the
appearance of a new site of phosphorylation. This
suggests that the phosphorylation state of CdclO may
constitute the signal that influences the developmental
fate of the cell. Since we have demonstrated that
CdclO is associated with Pucl and presumably Cdc2
but have not detected an association between Ranl
and CdclO, we propose that Ranl functions in this
capacity to control the Cdc2 execution point in G1 by
affecting the ability of Cdc2/Pucl to associate with
and phosphorylate CdclO. It is likely that the require-
ment for Ranl in the formation of an active CdclO/
Sctl transcription complex is due to its role in promot-
ing the Pucl/CdclO association.
Clearly, however, our knowledge of the role of
Pucl/Cdc2 at Start is incomplete in part because no
fission yeast cyclin has been definitively shown to
function in G1. Pucl is at present the best candidate of
DISCUSSION
The results presented in this article support a molec-
ular model for the regulation of Start in which the
Ranl kinase cooperates with Cdc2 to control Cdc10/
Sctl-dependent transcription during the fission yeast
cell cycle (Figure 8). Our data demonstrate that the
association of Sctl with CdclO to form an active tran-
scription complex requires the activity of the Ranl
protein kinase in vivo. Inactivation of ranl under re-
strictive conditions leads to the dissociation of CdclO
and Sctl and concomitant loss of DNA-binding activ-
ity. This leads to G1 arrest and the activation of the
mating pathway regardless of nutritional conditions.
We have shown that Pucl, and presumably Cdc2,
associates with CdclO in vivo and that Ranl is re-
quired for this interaction. In the accompanying arti-
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Figure 8. Model for the role of Ranl in CdclO/Sctl activity.
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known cyclins to function in G1 because it shares a
high degree of amino acid sequence similarity to
CLN3 from S. cerevisiae (Forsburg and Nurse, 1991).
Cells that carry the pucl null allele, like the budding
yeast mutants deleted for any single CLN, display no
defect in G1 /S-phase progression (Forsburg and
Nurse, 1994). Furthermore, cells that carry the pucl
null allele in combination with inactivating mutations
in cigl, cig2, cdc13, or ranl display no cell cycle defects
(T.C., unpublished observations). Thus, it appears ex-
tremely likely that an as yet unidentified cyclin must
exist that functions in G1 in the absence of Pucl since
Cdc2 is essential for G, progression and cell cycle
commitment. Nonetheless, the observation that over-
expression of pucl partially rescues the ranl-114 tem-
perature-sensitive mutation when considered with the
biochemical results presented herein strongly suggests
a role for the Pucl cyclin in maintaining mitotic cell
cycle progression.
As in the budding yeast, conjugation in fission yeast
is controlled in part by the reciprocal action of diffus-
ible pheromones that induce specific changes in cells
of the opposite mating type (for review, see Nielsen,
1993). In budding yeast, the addition of mating pher-
omone to vegetatively growing cells of the opposite
mating type induces a G1 arrest through the direct
inhibition of the CLN/CDC28 kinase complex by
FAR1 (McKinney et al., 1993; Peter et al., 1993). In
fission yeast, however, it has not been possible to
determine whether mating pheromones are capable of
inducing G, arrest directly because derepression of the
genes necessary for activation of the pheromone re-
sponse pathway requires nitrogen limitation, which
itself induces G1 arrest. Interestingly, cells that carry
inactivating mutations in ranl undergo G, arrest upon
addition of mating pheromone to nitrogen-rich me-
dium (Davey and Nielsen, 1994).
The Ranl protein kinase functions to negatively reg-
ulate sexual differentiation under conditions that pro-
mote vegetative growth. The loss of ranl can be sup-
pressed by overexpression of sctl or pucl, by the loss
of stel 1 or mei2, or by conditions that cause unregu-
lated cAMP-dependent kinase (cAPK) activity (Sipic-
zki, 1988; Sugimoto et al., 1991; Tanaka et al., 1992; for
review, see Nielsen et al, 1993; Forsburg and Nurse,
1994). Cells that carry a deletion of the sctl gene or
inactivating mutations in ranl, adenylate cyclase
(cyrl), or cAPK (pkal) undergo conjugation and sub-
sequent meiosis regardless of nutritional conditions
thereby bypassing the normal requirement for nitro-
gen limitation for activation of these pathways (Iino
and Yamamoto, 1985; Nurse, 1985; Maeda et al., 1990;
Caligiuri and Beach, 1993; Maeda et al., 1994). The
cAMP signaling pathway functions to prevent conju-
gation and meiosis, whereas Ranl appears to regulate
entry into meiosis exclusively. It has therefore been
suggested that Ranl and cAPK may phosphorylate
unique substrates but may also share a common sub-
set of target proteins. It will be of great interest to
determine whether cAPK also functions to control the
association between Pucl and CdclO. It has been
shown recently that the Stell transcription factor is a
substrate of Ranl and a site that is present in Stel I and
the Ranl inhibitor, Mei3, was identified (Li and
McLeod, 1996). This site is not found in Pucl but as the
authors mention, protein kinases do not always rec-
ognize a linear sequence but rather an element of
secondary structure. Further experiments will be re-
quired to determine whether Pucl is in fact also a
substrate of Ranl.
The control of transcription at Start in fission yeast
may exhibit similarity to other developmentally regu-
lated pathways in which a cyclin/cdk complex phos-
phorylates a transcription factor. In budding yeast, the
activity of the PH04 transcription factor is controlled
by the PHO80-PH085 (cycin/cdk) complex (Kaffman
et al., 1994). When cultures of budding yeast are grown
in high-phosphate-containing medium, the PH04
transcription factor is phosphorylated by the PH080/
PH085 cyclin-dependent kinase complex and the
transcription of the PH05 is repressed. Similarly, in
mammalian cells the cyclin A/Cdk2 and cyclin
E/Cdk2 holoenzymes have been identified in com-
plexes that contain E2F and p107 (Devoto et al., 1992;
Pagano et al., 1992). Thus, these interactions may rep-
resent an evolutionarily conserved mechanism by
which cells are able to integrate the transcription ap-
paratus with the cell cycle machinery and, thus, enable
them to make appropriate changes in gene expression
in response to external stimuli.
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